Screener
Summit Therapeutics SMMT Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Summit Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Summit Therapeutics’s 10-Q, filed August 6, 2024. Open the filing →
- Filed
- Aug 6, 2024
- Fiscal quarter
- Q2 FY2024
- Calendar quarter
- Q2 2024
- Accession
- 0001599298-24-000117
FAQ
- What is Summit Therapeutics's operating margin?
- Summit Therapeutics (SMMT) reported operating margin of -268,266.8% in Q2 2023.
- How has Summit Therapeutics's operating margin changed year-over-year?
- Summit Therapeutics's operating margin decreased by 6724.9% year-over-year, from -3,930.7% to -268,266.8%.
- What is the long-term trend for Summit Therapeutics's operating margin?
- Over 2 years (2020 to 2022), Summit Therapeutics's operating margin has grown at a 28.6% compound annual growth rate (CAGR), from -6,185.2% to -10,225.4%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Summit Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude